Xiangyu Pharmaceutical

Xiangyu Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical manufacturer specializing in the "Women and Children's Health" segment. Headquartered in Linyi, Shandong, the company is a core subsidiary of the Xiangyu Industrial Group and operates with a heritage dating back to 1944. Its diverse portfolio features over 130 products, including Traditional Chinese Medicines (TCM) and chemical drugs, with a strategic focus on gynecology, pediatrics, and psychiatry. Key commercial products include Compound Hongyi Buxue Oral Liquid for anemia and Puling Penyankang Granules for pelvic inflammatory disease. The company is recognized for its "Hong Mama" and "Yi Baobao" brands and maintains a strong R&D presence through its national enterprise technology center. Xiangyu Pharmaceutical is committed to the modernization of TCM and the expansion of its footprint in the domestic healthcare market.